Concord III (NYSE:CNDB) has entered into a definitive agreement to combine with fabless chipmaker GCT at an enterprise value of $461 million.
San Jose, California-based GCT manufactures 4G and 5G chips for telecom clients for uses in a variety of home internet, infrastructure and mobile phone applications. ...READ MORE
With what appears to be the impending bankruptcy of WeWork (NYSE:WE), it is beginning to feel like the end of an era, if not several eras.
Much of the focus has been the transition from WeWork’s eye-watering zenith at a $46 billion valuation and ambitions of irreversibly changing the world the way titans like Microsoft (NASDAQ:MSFT) or Google (NASDAQ:GOOG) did. ...READ MORE
Good morning! Watch this space moving forward as a roundup of evening filings as well as news nuggets to nibble on beside your morning coffee.
The end of the week is bringing a raft of de-SPAC earnings releases, but although the market is picking back up, the tune from this crop companies is likely to be sung in a minor key. ...READ MORE
Good morning! Watch this space moving forward as a roundup of evening filings as well as news nuggets to nibble on beside your morning coffee.
Futures are cheery once again on the hints from Fed Chair Jerome Powell that the body could be done with rate hikes. ...READ MORE
Good morning! Watch this space moving forward as a roundup of evening filings as well as news nuggets to nibble on beside your morning coffee.
Even with Halloween now passed, it has been a spooky week for deals trying to make it to close without getting the chop. ...READ MORE
Ares Acquisition Corporation (NYSE:AAC) has mutually terminated its combination with nuclear energy firm X-energy and will liquidate on or about November 7.
The news marks an unfortunate end for deal that the two sides put significant work into since announcing it in December 2022. ...READ MORE
Good morning! Watch this space moving forward as a roundup of evening filings as well as news nuggets to nibble on beside your morning coffee.
With futures up, there is potential that this morning sees movement from investors looking to cash in on the ole’ Halloween Indicator. ...READ MORE
Roth CH V (NASDAQ:ROCL) announced this morning that it has slackened its grip on a possible deal with Slacker, allowing the letter of intent with the podcasting platform expire and breaking off further talks. ...READ MORE
Good morning! Watch this space moving forward as a roundup of evening filings as well as news nuggets to nibble on beside your morning coffee.
Sometimes the best deals are those that you don’t do. ...READ MORE
Sagging commodity prices for metals has been bad news for the five metals miners that completed SPAC deals in over the past three years and potentially a complicating development for the four announced deals still pending close. ...READ MORE
Good morning! Watch this space moving forward as a roundup of evening filings as well as news nuggets to nibble on beside your morning coffee.
Another day has brought another SPAC EV deal (more on that to come), which is a sound these days as customary as church bells on Sunday. ...READ MORE
Good morning! Watch this space moving forward as a roundup of evening filings as well as news nuggets to nibble on beside your morning coffee.
Few companies have a better finger to the pulse of consumer spending than payments and card companies. ...READ MORE
Fortune Rise (NASDAQ:FRLA) has entered into a definitive agreement to combine with Water On Demand at a pro forma equity value of $72 million.
Clearwater, Florida-based Water On Demand provides water treatment services and is developing a unique royalty-based platform it intends to launch as an investment vehicle. ...READ MORE
Good morning! Watch this space moving forward as a roundup of evening filings as well as news nuggets to nibble on beside your morning coffee.
This morning brings news that a fresh airline SPAC deal may be brewing, following on the announcement of the first of its type between FlyBondi and Integral 1 (NASDAQ:INTE) last Friday. ...READ MORE
TenX Keane (NASDAQ:TENK) has entered into a definitive agreement with Citius Oncology with its parent company Citius Pharma receiving $675 million in equity consideration.
Cranford, New Jersey-based Citius Oncology is developing a leukemia drug that is nearing approval and could see the market by late 2024. ...READ MORE
Good morning! Watch this space moving forward as a roundup of evening filings as well as news nuggets to nibble on beside your morning coffee.
There are increasing signs that the capital markets and dealmaking are returning to normalcy, but there is still plenty of time for fits and starts before the end of the year. ...READ MORE
